Cargando…
34346 Pooled safety analysis of respiratory tract infections, including COVID-19, in psoriasis patients treated with secukinumab
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Mosby, Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465225/ http://dx.doi.org/10.1016/j.jaad.2022.06.800 |
| _version_ | 1784787748610113536 |
|---|---|
| author | Schulze-Koops, Hendrik Deodhar, Atul Voll, Reinhard E. Leipe, Jan Blauvelt, Andrew Leonardi, Craig Pournara, Effie Alarcon, Ivette Bao, Weibin Trivedi, Vivek Mease, Philip J. |
| author_facet | Schulze-Koops, Hendrik Deodhar, Atul Voll, Reinhard E. Leipe, Jan Blauvelt, Andrew Leonardi, Craig Pournara, Effie Alarcon, Ivette Bao, Weibin Trivedi, Vivek Mease, Philip J. |
| author_sort | Schulze-Koops, Hendrik |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9465225 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Mosby, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94652252022-09-12 34346 Pooled safety analysis of respiratory tract infections, including COVID-19, in psoriasis patients treated with secukinumab Schulze-Koops, Hendrik Deodhar, Atul Voll, Reinhard E. Leipe, Jan Blauvelt, Andrew Leonardi, Craig Pournara, Effie Alarcon, Ivette Bao, Weibin Trivedi, Vivek Mease, Philip J. J Am Acad Dermatol Article Published by Mosby, Inc. 2022-09 2022-09-12 /pmc/articles/PMC9465225/ http://dx.doi.org/10.1016/j.jaad.2022.06.800 Text en Copyright © 2022 Published by Mosby, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Schulze-Koops, Hendrik Deodhar, Atul Voll, Reinhard E. Leipe, Jan Blauvelt, Andrew Leonardi, Craig Pournara, Effie Alarcon, Ivette Bao, Weibin Trivedi, Vivek Mease, Philip J. 34346 Pooled safety analysis of respiratory tract infections, including COVID-19, in psoriasis patients treated with secukinumab |
| title | 34346 Pooled safety analysis of respiratory tract infections, including COVID-19, in psoriasis patients treated with secukinumab |
| title_full | 34346 Pooled safety analysis of respiratory tract infections, including COVID-19, in psoriasis patients treated with secukinumab |
| title_fullStr | 34346 Pooled safety analysis of respiratory tract infections, including COVID-19, in psoriasis patients treated with secukinumab |
| title_full_unstemmed | 34346 Pooled safety analysis of respiratory tract infections, including COVID-19, in psoriasis patients treated with secukinumab |
| title_short | 34346 Pooled safety analysis of respiratory tract infections, including COVID-19, in psoriasis patients treated with secukinumab |
| title_sort | 34346 pooled safety analysis of respiratory tract infections, including covid-19, in psoriasis patients treated with secukinumab |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465225/ http://dx.doi.org/10.1016/j.jaad.2022.06.800 |
| work_keys_str_mv | AT schulzekoopshendrik 34346pooledsafetyanalysisofrespiratorytractinfectionsincludingcovid19inpsoriasispatientstreatedwithsecukinumab AT deodharatul 34346pooledsafetyanalysisofrespiratorytractinfectionsincludingcovid19inpsoriasispatientstreatedwithsecukinumab AT vollreinharde 34346pooledsafetyanalysisofrespiratorytractinfectionsincludingcovid19inpsoriasispatientstreatedwithsecukinumab AT leipejan 34346pooledsafetyanalysisofrespiratorytractinfectionsincludingcovid19inpsoriasispatientstreatedwithsecukinumab AT blauveltandrew 34346pooledsafetyanalysisofrespiratorytractinfectionsincludingcovid19inpsoriasispatientstreatedwithsecukinumab AT leonardicraig 34346pooledsafetyanalysisofrespiratorytractinfectionsincludingcovid19inpsoriasispatientstreatedwithsecukinumab AT pournaraeffie 34346pooledsafetyanalysisofrespiratorytractinfectionsincludingcovid19inpsoriasispatientstreatedwithsecukinumab AT alarconivette 34346pooledsafetyanalysisofrespiratorytractinfectionsincludingcovid19inpsoriasispatientstreatedwithsecukinumab AT baoweibin 34346pooledsafetyanalysisofrespiratorytractinfectionsincludingcovid19inpsoriasispatientstreatedwithsecukinumab AT trivedivivek 34346pooledsafetyanalysisofrespiratorytractinfectionsincludingcovid19inpsoriasispatientstreatedwithsecukinumab AT measephilipj 34346pooledsafetyanalysisofrespiratorytractinfectionsincludingcovid19inpsoriasispatientstreatedwithsecukinumab |